Allergan introduces hybrid injectable
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).